185 related articles for article (PubMed ID: 27623211)
1. Novel chemokine-like activities of histones in tumor metastasis.
Chen R; Xie Y; Zhong X; Fu Y; Huang Y; Zhen Y; Pan P; Wang H; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Fan XG; Tang D; Kang R
Oncotarget; 2016 Sep; 7(38):61728-61740. PubMed ID: 27623211
[TBL] [Abstract][Full Text] [Related]
2. Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma.
Liu WT; Jing YY; Yu GF; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX
Cancer Lett; 2015 Mar; 358(2):136-143. PubMed ID: 25511737
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 4 signaling promotes invasion of hepatocellular carcinoma cells through MKK4/JNK pathway.
Dong YQ; Lu CW; Zhang L; Yang J; Hameed W; Chen W
Mol Immunol; 2015 Dec; 68(2 Pt C):671-83. PubMed ID: 26589455
[TBL] [Abstract][Full Text] [Related]
4. Extracellular HSP70-peptide complexes promote the proliferation of hepatocellular carcinoma cells via TLR2/4/JNK1/2MAPK pathway.
Zhe Y; Li Y; Liu D; Su DM; Liu JG; Li HY
Tumour Biol; 2016 Oct; 37(10):13951-13959. PubMed ID: 27492456
[TBL] [Abstract][Full Text] [Related]
5. A896G and C1196T Polymorphisms Within the TLR4 Gene Abate Toll-Like Receptor 4-Mediated Signaling in HepG2 Cells.
Huang C; Zhang H; Bai R; Wang L; Lv J
DNA Cell Biol; 2017 Nov; 36(11):1029-1038. PubMed ID: 28945461
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways.
Liu J; Chen S; Wang W; Ning BF; Chen F; Shen W; Ding J; Chen W; Xie WF; Zhang X
Cancer Lett; 2016 Aug; 379(1):49-59. PubMed ID: 27216982
[TBL] [Abstract][Full Text] [Related]
7. Soluble B7-H3 promotes the invasion and metastasis of pancreatic carcinoma cells through the TLR4/NF-κB pathway.
Xie C; Liu D; Chen Q; Yang C; Wang B; Wu H
Sci Rep; 2016 Jun; 6():27528. PubMed ID: 27273624
[TBL] [Abstract][Full Text] [Related]
8. Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration.
Liao SJ; Zhou YH; Yuan Y; Li D; Wu FH; Wang Q; Zhu JH; Yan B; Wei JJ; Zhang GM; Feng ZH
Breast Cancer Res Treat; 2012 Jun; 133(3):853-63. PubMed ID: 22042369
[TBL] [Abstract][Full Text] [Related]
9. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
Hsieh SC; Tsai JP; Yang SF; Tang MJ; Hsieh YH
Amino Acids; 2014 Dec; 46(12):2809-22. PubMed ID: 25245054
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L
Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide-induced toll-like receptor 4 signaling in cancer cells promotes cell survival and proliferation in hepatocellular carcinoma.
Wang L; Zhu R; Huang Z; Li H; Zhu H
Dig Dis Sci; 2013 Aug; 58(8):2223-36. PubMed ID: 23828139
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages.
Loniewski KJ; Patial S; Parameswaran N
Mol Immunol; 2007 Jul; 44(15):3715-23. PubMed ID: 17507094
[TBL] [Abstract][Full Text] [Related]
13. Lactobacillus delbrueckii TUA4408L and its extracellular polysaccharides attenuate enterotoxigenic Escherichia coli-induced inflammatory response in porcine intestinal epitheliocytes via Toll-like receptor-2 and 4.
Wachi S; Kanmani P; Tomosada Y; Kobayashi H; Yuri T; Egusa S; Shimazu T; Suda Y; Aso H; Sugawara M; Saito T; Mishima T; Villena J; Kitazawa H
Mol Nutr Food Res; 2014 Oct; 58(10):2080-93. PubMed ID: 24995380
[TBL] [Abstract][Full Text] [Related]
14. Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of toll-like receptor 4.
Kato S; Yuzawa Y; Tsuboi N; Maruyama S; Morita Y; Matsuguchi T; Matsuo S
J Am Soc Nephrol; 2004 May; 15(5):1289-99. PubMed ID: 15100369
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling.
Wang Y; Cai J; Zeng X; Chen Y; Yan W; Ouyang Y; Xiao D; Zeng Z; Huang L; Liu A
BMC Cancer; 2015 Oct; 15():821. PubMed ID: 26514586
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor (TLR) 2 induced through TLR4 signaling initiated by Helicobacter pylori cooperatively amplifies iNOS induction in gastric epithelial cells.
Uno K; Kato K; Atsumi T; Suzuki T; Yoshitake J; Morita H; Ohara S; Kotake Y; Shimosegawa T; Yoshimura T
Am J Physiol Gastrointest Liver Physiol; 2007 Nov; 293(5):G1004-12. PubMed ID: 17855767
[TBL] [Abstract][Full Text] [Related]
17. Alternative TLRs are stimulated by bacterial ligand to induce TLR2-unresponsive colon cell response.
Mukherjee S; Biswas R; Biswas T
Cell Signal; 2013 Aug; 25(8):1678-88. PubMed ID: 23665374
[TBL] [Abstract][Full Text] [Related]
18. Naringenin suppresses TPA-induced tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells.
Yen HR; Liu CJ; Yeh CC
Chem Biol Interact; 2015 Jun; 235():1-9. PubMed ID: 25866363
[TBL] [Abstract][Full Text] [Related]
19. MiR-491 attenuates cancer stem cells-like properties of hepatocellular carcinoma by inhibition of GIT-1/NF-κB-mediated EMT.
Yang X; Ye J; Yan H; Tang Z; Shen J; Zhang J; Yang L
Tumour Biol; 2016 Jan; 37(1):201-9. PubMed ID: 26188902
[TBL] [Abstract][Full Text] [Related]
20. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.
Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW
Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
